Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT01650792

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01650792
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01650792. Randomized; single masking; primary purpose treatment. Start 2012-07 (actual); primary completion 2024-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)
Acronym
CLINICS
Condition
Chagas Disease With Heart Failure
Intervention (Drug)
Aspirin
Lead sponsor
Federal University of Bahia (class: other)
Collaborator
National Institutes of Health (NIH) (class: US National Institutes of Health)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct01650792
Content hash
6fda4154a68f00cfb87cd79f3415cd71c8dd23b4570f8d8bd923c3c60e2d48bb